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Tenascin C is expressed in invasive human solid tumors; however its specific role in cancer biology remains obscure. Previously, we have
found that ecto-5′-nucleotidase (eN) is a marker of ER (−) breast carcinoma and elevated expression correlates with invasive mesenchymal cell
phenotype. To investigate for the potential relationship between eN and protein components of the extracellular matrix (ECM) we measured
adenosine generation from AMP in cells incubated with soluble ECM proteins. We found that tenascin C was the only ECM component that
strongly inhibited ecto-5′-nucleotidase (eN) activity in situ and adenosine generation from AMP (75% inhibition, p b 0.01). The inhibition was
comparable to that induced by concanavalin A, a well-defined and strong inhibitor of eN. Resin immobilized tenascin C, but not collagen, and
only weakly fibronectin, specifically and quantitatively bound cell-extracted eN. We further developed breast cancer cell line with reduced eN
expression and tested changes in cell adhesion on different ECM. Breast cancer cells expressing reduced eN attached 56% weaker (p b 0.05) to
immobilized tenascin C. This difference was not detected with other ECM proteins. Finally, control breast cancer cells migrated slower on tenascin
C when compared with clone with reduced eN expression. These data suggest that eN is a novel and specific receptor for tenascin C and that the
interaction between these proteins may influence cell adhesion and migration and also lead to decreased generation of local adenosine.
© 2007 Elsevier B.V. All rights reserved.Keywords: Ecto-5′-nucleotidase; CD73; Adenosine; Breast cancer; Extracellular matrix; Tenascin C; Cell adhesion; Cell motility; Invasion1. Introduction
Extracellular matrix (ECM) has been established as a major
factor regulating epithelial cell behavior and epithelial–mesench-
ymal interactions [1]. These regulatory functions may be critical
in many physiological situations, for example during develop-
ment and in pathological circumstances such as wound healing
and cancer progression. Tenascin C belongs to non-structural
ECM proteins that are believed to regulate cell adhesion and
migration and to have signaling altering functions [2,3]. For
example tenascin C has shown strong anti-adhesive properties☆ This work was supported by grants RO1-CA34085 from the National
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doi:10.1016/j.bbadis.2007.11.001and counteracted cell adhesion to fibronectin by disrupting focal
adhesion sites. Cells spread on tenascin C lack focal adhesions
and actin stress fibers and instead form substratum contacts with
radial actin microspikes [4,5]. Tenascin C has been reported to
bind (mostly through its FnIII domain) integrins, proteoglycans,
cell adhesion molecules of immunoglobulin family and other
ECM proteins and these complex interactions affected both Rho-
mediated and Wnt signaling pathways [6].
Ecto-5′-nucleotidase (eN), an enzyme residing in lipid rafts,
was previously proposed to directly interact with laminin and
fibronectin in chicken gizzard [7,8]. These studies suggested that
eN, in addition to its adenosine generating functions, may par-
ticipate in cell adhesion. We have demonstrated previously
that eN and its enzymatic product adenosine are upregulated
during breast cancer progression [9]. We have also shown that
Wnt signaling pathway, which is frequently activated in epithe-
lial tumors, activated eN expression and increased adenosine
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adhesion and motility [11–13] and previously described direct
adhesive properties of eN, we set out to investigate whether eN
may be involved in cell adhesion in metastatic breast cancer
cells. In this communicationwe report that in human breast cancer
cells eN strongly and specifically interacts with tenascin C
and this interaction leads to (1) decreased generation of ade-
nosine, (2) increased adhesion and, (3) decreased migration on
tenascin C.
2. Methods
2.1. Reagents
Anti-eN rabbit polyclonal antibodies were described previously [14]. Anti-
integrin β1 I41720, integrin α5 I55220 antibodies were from Transduction
Laboratories (Lexington, KY), anti-CD44s 13-5500 antibody was from Zymed
(San Francisco, CA), anti-GFP antibodies were from Clontech BD Biosciences,
(Mountain View, CA) and anti-β-actin antibodies were from Oncogene (Boston,
MA). Human ECM proteins tenascin-C, fibronectin, vitronectin and laminin
were from Chemicon (Temecula, CA), hyaluronic acid and ConA were from
Sigma-Aldrich (St Louis, MO) and Matrigel and collagen IV were from BD
Biosciences (Franklin Lakes, NJ). Cell culture media and FBS were from Gibco
Invitrogen, Carlsbad, CA.
2.2. Measurements of extracellular adenosine generation from AMP
(in situ assay)
Breast cancer MDA-MB-231 cells and its derivatives (low eN and GFP-
expressing clones) were plated at 750 to 1000 cells per well in 96 wells flat bottom
plates. 24h after plating medium was changed to 80μl of serum-free Opti-MEM
(Gibco Invitrogen, Carlsbad, CA) with specific soluble ECM protein at 25μg/ml
(ConA at 5mg/ml) and cells were preincubated for additional 30min. Reaction
was started by the addition of a mixture of {8-14C} AMP (final concentration
100μM, 3 × 105cpm/well) and dipyridamole (inhibitor of adenosine uptake, final
concentration 10μM), in a final total volume of 200μl/well. Samples (25μl each)
were withdrawn at 0, 30 and 60min and analyzed for radiolabeled adenosine by
TLC on a Kodachromemicrocrystalline cellulose plates with fluorescent indicator.
Adenosine and inosine spots were cut out and quantitated in scintillation counter
as described before [10]. Results from 30 and 60min time points were used to
calculate average values. No radioactive IMP or other nucleoside degradation
products were detected in significant amount (more than 3% of adenosine, as
resolved on PEI-cellulose) in preliminary experiments. Rates of adenosine gen-
eration were linear within the times specified and the maximal amount of de-
phosphorylated AMP never exceeded 20%.
2.3. Cell adhesion assay
Cells were plated on 96-well plates (density 105 cells per well) pre-coated
overnight (16h) with 50μg/ml (200μl) of ECM protein in PBS at RT. Plates were
transferred to 37°C for 30min pre-incubation and cells were allowed to adhere for
30min in serum-freeMEMmedium at 37°C.After incubation plates werewashed
3 timeswith PBS to remove nonattached cells and adherent cells were quantitated
with mitochondrial dye WST-1 supplied ready to use (1mg/ml) from Roche
Diagnostics (Indianapolis, IN). Absorbance was measured within 30min at
450nm. Each experiment was done in duplicates and repeated 3 to 4 times.
2.4. Cell lines and development of eN-depleted and GFP-expressing
MDA-MB-231 cell clones
Breast cancer ER negative MDA-MB-231 cells were obtained from Tissue
Culture Facility at LCCC/UNC and originated from ATCC. Cells were maintained
inMEM supplemented with Eagle salts, NaPyr, nonessential amino acids and 10%
FBS as described before (Spychala, 2005).To downregulate the expression of eN in MDA-MB-231 cells we have
employed retrovirally mediated expression of anti-sense cDNA with pLNCX2
retroviral vector system from Clontech BD Biosciences, Mountain View,
CA. Green Fluorescent Protein (EGFP) (Clontech) was used in control cells
(pEGFP-N1 vector). We have generated the 1754bp eN cDNA fragment using
PCR with primers containing cloning sites SalI and XhoI. This fragment (1754bp)
started at 4th base of the coding region and spanned over the remaining of the eN
coding and small part of the 5′-untranslated regions, and included added ATG site
in reverse orientation at the 3′ end. This cDNAwas cloned into pLNCX2 vector in
reverse orientation and used to transfect PT67 cells (supplied with the transfection
kit from Clontech BD Biosciences) to produce viral particles. PT67 cell trans-
fections were performed using CalPhos Mammalian Transfection Kit according
to the manufacturer protocol. Supernatants from transfected PT67 cells 48h
postransfection (containing viral particles) were used to transfect MDA-MB-231
grown at 15–20% confluency. TransfectedMDA-MB-231 cells were selectedwith
increasing concentrations of G418 (from 0.2 to 1.5mg/ml) starting 24h post-
transfection. Selected polyclonal cell population was further subcloned by limiting
dilution and several clones for each transfection were expanded and tested for the
expression of eN and GFP. Selected cell stocks were stored in liquid nitrogen and
each sample was kept in culture for no more than 15 passages.
2.5. Resin immobilization of ECM proteins and column chromatography
of cell extracts
One milliliter of packed activated resin for each ECM protein from Aminolink
Kit (Pierce, Rockford, Il) was prepared as described in manufacturers protocol and
coupledwith 1mg each of tenascin C, fibronectin and collagen IV (each pre-dialyzed
against PBS over night at 4°C). Less then 10% of protein was left uncoupled. After
coupling resins were placed in small columns (3ml volume) and washed with PBS
supplemented with 1mMZnCl2 andMgCl2. Cells extracts for chromatography were
prepared using the following procedure. Harvested MDA-MB-231 cell pellets
(collected from10225cm2 culture dishes at 60–75%confluency, total 7.5 × 108 cells)
were extracted with 25mM Tris, pH 7.5 and 1% Triton X-100 in Dounce homo-
genizer, diluted 4 times with PBS supplemented with 1mM ZnCl2 and MgCl2 and
incubated 1h at room temperature with 500U of phosphatidylinositol-specific
phospholipase C (Sigma, St Louis, MO). Following incubation crude extracts were
centrifuged at 10,000g for 10min and clear supernatants were divided into 3 equal
portions and applied on each column at 25mg of total extract protein in 10ml volume
per each column at RT. Columns were washed with PBS supplemented with 1mM
ZnCl2 and MgCl2, and step-wise elution was performed with increasing con-
centrations of NaCl supplemented with 1mM ZnCl2 and MgCl2. Ten 1ml fractions
were collected per each elution condition. Protein amount was determined in each
fraction using Bradford reagent and peak fractions (in each case there were only 2
peak fractions representing total protein eluted under each condition)were combined.
25μl samples were withdrawn for eN protein detection by Western blot. Thus, the
procedure described above allows for direct comparison of immunoblot band
intensities between samples from different columns.
2.6. Western blot analysis
Harvested cells were extracted with 20mM Tris, pH 7.4 and 0.2mM PMSF
by triple thaw/freeze (37°C/− 70°C) and protein concentration in whole homo-
genates was assayed by Bradford method. Samples of 20μg were loaded into
each lane and separated in 10% polyacrylamide gel according to Laemmli
procedure (SDS-PAGE). Resolved proteins were subsequently transferred onto
Immobilon-P membrane (Millipore, Bedford, MA). Membranes were blocked
either in PBS (pH 7.4) or in TBS (pH 8.4), both supplemented with 5%Carnation
nonfat dry milk and 0.1% Tween-20. Secondary antibody was conjugated with
horse radish peroxidase and chemiluminescence developed with BM chemilu-
minescence western blotting kit (Roche, Indianapolis, IN) and detected onKodak
(Rochester, NY) X-Mat Blue XB-1 film.
2.7. Real time video tracking of cell movements
MDA-MB-231 control (GFP clone H2) and eN-depleted (eN(−) clone 12-1)
cells were plated 2.5h before experiment in suspension cell culture dishes pre-
coated with tenascin or no coating (plastic). After 2.5h they were transferred to a
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the Olympus IX81 inverted microscope. The temperature of the chamber was
kept at 37°C and CO2 flow was maintained over the cell culture dish. Micro-
scope was equipped with Hamamatsu 4880 cooled CCD camera. Sequential
time lapse images were taken every 5min with 20× Ph1 objective for 3h. Time
lapse sequences were then stored and analyzed off-line using Metamorph soft-
ware package (Universal Imaging). Motility of every cell was determined by
manual tracking of the cell position through time lapse sequence and automatic
calculation of the traveled distance was performed by standard Metamorph
routines. Tracking data were then transferred to Excel spreadsheet where the
final numerical analysis was performed.Fig. 2. Western blots of affinity column eluates. Wash represents volume collected
during extract application and subsequent wash with PBS supplemented with
1 mM ZnCl2 and MgCl2, and concentrated to 10 ml for direct comparison with
extract before application. For other samples protein containing fractions were
combined and used directly for SDS-PAGE.3. Results
Ecto-5′-nucleotidase is the main source of adenosine in epi-
thelial cells [15] and we have tested the effect of soluble
tenascin C, laminin, collagen IV, vitronectin, hyaluronic acid
and matrigel (all at 25μg/ml) on the adenosine generation from
AMP by attached MDA-MB-231 breast cancer cells. Data shown
in Fig. 1 demonstrate that soluble tenascin C inhibited the ade-
nosine generation from AMP by ecto-5′-nucleotidase by 75.8%
(p b 0.01, n = 3). This enzyme is the major adenosine producing
activity in breast cancer cells and, accordingly, Concanavalin A
(ConA), a specific eN inhibitor decreased adenosine production
to a similar extent. Other ECM proteins either did not signi-
ficantly affect eN activity, or as in the case of vitronectin and
fibronectin, inhibited adenosine generation only weakly, although
in the case of vitronectin the inhibition did reach the significance
of p b 0.05 (n = 3, ANOVA t-test).Fig. 1. Effect of soluble extracellular matrix proteins on adenosine generation
from AMP in MDA-MB-231 cells. The amounts of generated adenosine and
inosine from AMP were representative of eN in situ activity and compared
between different ECM proteins added. Control cells did not contain any added
protein. Conversion rates of AMP to adenosine/inosine were calculated and
compared with the rate in control wells (1195±322 nmol/h/106 cells, relative
100%). Data represent mean±SD from 3–4 experiments. Statistical analysis was
performed using ANOVA t-test.To further evaluate whether there is a direct and specific
interaction between eN and tenascin C and possibly other ECM
proteins, we have immobilized tenascin C, fibronectin and
collagen IV on resin to investigate whether solubilized eN will
be retained in the column in the ECM protein-specific manner.
For this purpose we used eN solubilized with phosphatidyli-
nositol-specific phospholipase C (PLC) from MDA-MB-231
cell extracts. As shown in Fig. 2, when each column was
loaded with equal amount of eN, only the column with immo-
bilized tenascin C retained most of applied eN (as determinedFig. 3. The expression of eN and GFP and three representative adhesion proteins in
wild type and stably selectedMDA-MB-231 cell clones after transfectionwith sense
GFP and anti-sense eN cDNA and. The adenosine generation rates fromAMP in an
in situ assay in obtained clones were: 1) w/t 1302+409; 2) GFP 4F 1049+389; 3)
GFP 2H 1245+420; 4) eN(−) 12-1 92+44; 5) eN(−) 6H 128+58 nmol/h/106 cells.
Fig. 5. The migration of control (GFP-2H) and eN-depleted MDA-MB-231
clones on plates pre-coated with tenascin C. Data represent mean±SD from 3
experiments.
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with immobilized fibronectin and no retention was observed
with collagen IV. Furthermore, increasing concentrations of
NaCl eluted column-bound eN in higher amounts and at higher
NaCl concentrations from tenascin C column than from fibro-
nectin column.
To investigate the interaction of eN with tenascin C and its
potential significance in cell adhesion and migration we have
developed a derivative of MDA-MB-231 cells with decreased
expression of eN, achieved with stable expression of anti-sense
eN cDNA. As shown in Fig. 3 two clones with anti-sense
cDNA and GFP sense (control cells) each were selected and
tested for expression of several proteins. Both eN anti-sense
clones had eN expression reduced by over 90% as determined
by enzymatic activity assay (see legend for Fig. 3). Represen-
tative membrane proteins that are important in cell adhesion,
such as CD44, integrins β1 and α5 were not significantly
affected. These cells were subsequently used to compare the
adhesion of cells to different substrata. Data shown in Fig. 4
demonstrate that while the low eN expression did not have
significant effect on adhesion to plastic, collagen IV, laminin,
fibronectin and vitronectin, the adhesion on tenascin C was
reduced by approximately 50% (p b 0.05, n = 4) in cells with
low eN expression.
MDA-MB-231 cells were previously shown to migrate on
several substrata and we hypothesize that altered adhesion on
tenascin C may influence cell motility of eN(−) clone. We haveFig. 4. Adhesion assay of control (GFP-expressing) and eN-depleted (eN(−) 6H)
MDA-MB-231 clones on 96 well plates pre-coated with ECM proteins.
Readings of absorbance at 450 nm were taken to calculate the mean absorbance
values. Data represent mean±SD from 3–4 experiments. Statistical analysis was
performed using ANOVA t-test.used video tracking technique to test the migration velocity.
Data shown in Fig. 5 demonstrate that downregulation of eN
caused increase in cell mobility on tenascin C. However, the cell
mobility increase did not reach the significance of pb0.05.
4. Discussion
Tenascin C is highly expressed during development and in
tumor stroma and its expression is negatively correlated with
the survival prognosis of patients with glioma, breast and gas-
tric tumors [6,16]. It has been detected in many other solid
tumors and in sarcomas, however its relation to tumor inva-
siveness is not fully understood. Although initial findings sug-
gested that tenascin C had anti-adhesive properties in the
context of other ECM proteins such as fibronectin, it is now
recognized that these interactions may be cell-type specific. An
example that illustrate this cell-specific behavior has been pre-
sented [17] and shows that when plated on patterned ECM
substrates, sensory neuritis easily crossed borders between la-
minin and tenascin C, however satellite cells stopped migrating
and lined up at borders to tenascin C. Other reports also de-
monstrate that tenascin C may have both pro-migratory and
anti-migratory properties, depending on cell type and ECM
composition. Such complex behavior suggests that there are
other tenascin C receptors and/or interacting proteins expressed
on cell surface that may regulate migration and invasiveness in
a cell-specific manner.
We propose that ecto-5′-nucleotidase (eN) is a novel receptor
for tenascin C. Data presented in Figs. 1 and 2 demonstrate
that there is highly specific interaction of eN with tenascin C
and this interaction influences cell adhesion, migration (Figs. 4
and 5) and adenosine generation. Previously, chicken gizzard
39R. Sadej et al. / Biochimica et Biophysica Acta 1782 (2008) 35–40ecto-5′-nucleotidase was shown to interact with laminin and
fibronectin [7,8], however our data show that in the case of
human eN there was relatively weak interaction with fibro-
nectin and no interaction with laminin. The interaction of
avian eN with tenascin C has not been investigated. Among 7
ECM proteins tested in this work, only tenascin C potently
inhibited eN enzymatic activity. The strong interaction of eN
with tenascin C, as determined by column chromatography,
and the inhibition of eN enzymatic activity by soluble tena-
scin C, both support the physiological significance of this
interaction. In addition, altered generation of adenosine, a
known regulator of adhesion and migration, further implicate
adenosine as an additional effector of this interaction. Adeno-
sine was shown, depending on the adenosine receptor sub-
type, to exhibit anti-adhesive properties [11–13]. One may
thus propose that upon eN–tenascin C interaction, decreased
local generation of adenosine may further enhance the ad-
hesive properties of tenascin C toward cells with high eN
expression. In simple terms, such interaction would actually
decrease metastatic behavior of cells expressing high eN,
however this notion will require further investigation. Our
results may potentially help reconcile previous conflicting
findings showing that in human cancer tenascin C correlated
with both poor and favorable clinical prognosis, depending on
the tumor type [16]. One may speculate that metastatic cells
that do not express specific tenascin C receptors (such as eN)
may have enhanced motility due to its mostly anti-adhesive
properties. Conversely, cells with high eN or other tenascin C
receptors would have impaired motility in the presence of
extracellular tenascin C. The in vivo scenario is likely to be
much more complex due to the unknown source of
extracellular tenascin C in each particular setting. Is tenascin
C produced by the same cells as is eN or it may be discharged
by other type of cells and in this way impair the migration of
eN expressing cells? Or is there a potential for self regulation
of eN by cells producing their own tenascin C?
It is not yet clear if tenascin C and eN expression correlate
during development and in tumorigenesis. Our previous studies
demonstrate that Wnt signaling, which has a role in inducing the
expression of tenascin C [18], may also control eN expression
[10], suggesting that there may be a particular circumstance
for the co-expression of these two proteins. Furthermore, in a
broad panel of breast cancer cell lines eN expression correlated
with a mesenchymal expression profile that was coordinately
altered by inhibition of histone deacetylases [19]. These data
suggest that eN, along with vimentin and other mesenchymal
proteins, potentially including tenascin c, may be coordinately
regulated during development and in tumorigenesis. However,
the co-expression of these proteins in tumor samples and
any functional links between them in vivo have yet to be
established.
eN may be directly involved in tumor cell invasion through
production of adenosine from extracellular AMP or through
protein–protein interactions with other cell surface or ECM
proteins. Very recent reports on overexpression of eN in T-47D
breast cancer cells indicate that adenosine generated from
eN may be a positive factor in motility and invasion [20]. Thisinteresting observation could be collaborated by earlier find-
ings on the role of adenosine receptors in adhesion (reviewed in
[21]). However, the eN inhibitor AMPCP used in this study
appears to have additional effects on purinergic receptors and
on nucleotide metabolism [15], that may independently affect
cell behavior and, thus, the enzymatic role of eN in breast
cancer invasion will have to be independently confirmed. On
the other hand, direct engagement of eN using either specific
monoclonal antibodies or ConA, a specific eN-binding
inhibitor, have been shown to exert profound effects on T-
cell activation [22]. These observations opened up the
possibility that a specific eN interacting protein(s) may trigger
an intracellular signaling cascade. However, such interacting
protein has not yet been identified. Although our present study
suggests that tenascin C may be such eN interacting partner, the
signaling properties of such interaction, if any, will need to be
addressed in future studies.
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